Weiran Cheng

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
As the first clinically approved gadolinium-based blood-pool MRI contrast agent, gadofosveset was designed to bind to human serum albumin (HSA) reversibly, extending the circulation time in the bloodstream. This valuable pharmacokinetic property required for vasculature imaging, however, raises the risk of release and accumulation of gadolinium in vivo. The(More)
  • 1